Incidence and Factors Associated to the Development of PICS-F Among ICU Relatives: A Longitudinal Exploratory Study

April 5, 2024 updated by: Cristobal Padilla, Pontificia Universidad Catolica de Chile

Incidence and Factors Associated to The Development of Post-Intensive Care Syndrome Among Family Members of Intensive Care Unit Survivors: A Longitudinal Exploratory Study

The constellation of long-term psychological, physical, and cognitive impairments arising after a critical illness among family members of ICU survivors has been labeled as "Post Intensive Care Syndrome - Family" (PICS-F). Despite PICS-F awareness, the long-term issues faced by ICU family members remain poorly understood with several gaps in knowledge remaining such as the role of protective psychosocial factors, caregiver burden, or family satisfaction in the development of the syndrome.

This single-center, longitudinal exploratory study, aims to determine the incidence of each PICS-F impairment (psychological, physical, and cognitive) and to identify factors (during ICU stay and after hospital discharge) associated with the development or prevention of the PICS-F impairments among family members of ICU survivors of a public hospital in Chile.

Study Overview

Detailed Description

During the last decades, intensive care unit (ICU) mortality rates have significantly decreased but not without adverse health-related consequences for patients and their family members. Admission to an ICU is often a stressful and traumatic experience for family members, leading to adverse psychosocial outcomes lasting beyond 12 months after hospital discharge.

The constellation of long-term psychological, physical, and cognitive impairments arising after a critical illness among family members of ICU survivors, has been labeled as "Post Intensive Care Syndrome - Family" (PICS-F). PICS-F is now being recognized as a public health burden with substantial associated costs. Despite PICS-F awareness, the long-term issues faced by ICU family members remain poorly understood with several gaps in knowledge remaining unanswered.

First, PICS-F evidence (incidence and related factors) is focused predominantly on psychological impairments with few studies exploring physical and cognitive impairments. Equally, studies on the influence of psychosocial resources (e.g., resilience, social support), which could offset PICS-F-related stress, are limited. Second, while up to 80% of the ICU family members become caregivers after the patient's hospital discharge, the effect of caregiver burden on PICS-F has received little attention. Third, is not clear the extent to which the family member´s evaluation of the ICU experience, known as family satisfaction, or other variables measured in this period can influence PICS-F.

The aim of this study is two-fold, one cross-sectional and one longitudinal aim. Among family members of ICU survivors of a public hospital in Chile, this study aims:

  1. To determine the incidence of each PICS-F impairment (psychological, physical, and cognitive).
  2. To identify factors associated with PICS-F impairments during ICU stay and after hospital discharge.

Study Type

Observational

Enrollment (Estimated)

175

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Cristobal Padilla F., PhD
  • Phone Number: +56964587104
  • Email: cfpadill@uc.cl

Study Locations

    • RM
      • La Florida, RM, Chile
        • Recruiting
        • Hospital Clinico Dra. Eloisa I. Diaz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Family members of ICU survivors in a public hospital in Santiago, Chile who meet the inclusion criteria will be invited to the study.

Description

Inclusion Criteria:

All adult family members (≥ 18 years old) identified as the patient´s representative, Spanish speakers, and likely to become responsible for providing and/or coordinating patient care after hospital discharge will be eligible.

Besides, the patient must have between 48 hours and 10 days in the ICU, be > 18 years old, and receive respiratory support (noninvasive ventilation, high-flow nasal cannula, or invasive mechanical ventilation).

Exclusion Criteria:

Family members of ICU patients with a high impending death risk (including end-of-life care / only comfort measures) or likely to be discharged from the ICU in the following 24 hours will be excluded.

Subjects (family members) will be withdrawn from the study at any point if the patient dies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Family Members
Family members of patients admitted to the ICU between the 1st of May 2025 and the 30th of May 2023, who survived ICU stay and are still alive up to 6 months after hospital discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of psychological impairment in family members of ICU survivors
Time Frame: 3 months after hospital discharge

Symptoms of anxiety and depression (1) or Post-traumatic stress disorder (PTSD) (2) (1 or 2):

  1. Anxiety and depressive symptoms measured using the 4-item version of the Patient Health Questionnaire (PHQ - 4), summed score range from 0 (best) to 12 (worst). Presence of symptoms of anxiety and depression if summed PHQ - 4 score ≥ 6.
  2. PTSD symptoms measured using the 6-item version of the Impact of Event Scale (IES - 6), summed score range from 0 (best) to 24 (worst). Presence of PTSD symptoms if averaged IES - 6 score ≥ 1.75.
3 months after hospital discharge
Incidence of psychological impairment in family members of ICU survivors
Time Frame: 6 months after hospital discharge

Symptoms of anxiety and depression (1) or Post-traumatic stress disorder (PTSD) (2) (1 or 2):

  1. Anxiety and depressive symptoms measured using the 4-item version of the Patient Health Questionnaire (PHQ - 4), summed score range from 0 (best) to 12 (worst). Presence of symptoms of anxiety and depression if summed PHQ - 4 score ≥ 6.
  2. PTSD symptoms measured using the 6-item version of the Impact of Event Scale (IES - 6), summed score range from 0 (best) to 24 (worst). Presence of PTSD symptoms if averaged IES - 6 score ≥ 1.75.
6 months after hospital discharge
Incidence of physical impairment in family members of ICU survivors
Time Frame: 3 months after hospital discharge
Symptoms of clinically significant fatigue. Clinical fatigue measured using 4 items of the "energy/fatigue" subscale (Vt) of the Short Form Health Survey (SF - 36). Averaged score range from 100 (best) to 0 (worst): Presence of clinical fatigue if averaged SF - 36 Vt score < 45.
3 months after hospital discharge
Incidence of physical impairment in family members of ICU survivors
Time Frame: 6 months after hospital discharge
Symptoms of clinically significant fatigue. Clinical fatigue measured using 4 items of the "energy/fatigue" subscale (Vt) of the Short Form Health Survey (SF - 36). Averaged score range from 100 (best) to 0 (worst): Presence of clinical fatigue if averaged SF - 36 Vt score < 45.
6 months after hospital discharge
Incidence of cognitive impairment in family members of ICU survivors
Time Frame: 3 months after hospital discharge
Cognitive impairment measured using the memory, fluency, and orientation (MEFO) test. Summed score range from 13 (best) to 0 (worst). Presence of cognitive impairment if summed MEFO test score < 9.
3 months after hospital discharge
Incidence of cognitive impairment in family members of ICU survivors
Time Frame: 6 months after hospital discharge
Cognitive impairment measured using the memory, fluency, and orientation (MEFO) test. Summed score range from 13 (best) to 0 (worst). Presence of cognitive impairment if summed MEFO test score < 9.
6 months after hospital discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptoms of Anxiety and Depression in family members of ICU survivors
Time Frame: Between the 3rd - 7th day of ICU admission
Anxiety and depressive symptoms measured using the PHQ - 4, summed score range, 0 (best) to 12 (worst)): Presence of symptoms of anxiety and depression if summed PHQ - 4 score ≥ 6.
Between the 3rd - 7th day of ICU admission
Symptoms of Anxiety and Depression in family members of ICU survivors
Time Frame: Up to 1 week after ICU discharge
Anxiety and depressive symptoms measured using the PHQ - 4, summed score range, 0 (best) to 12 (worst)): Presence of symptoms of anxiety and depression if summed PHQ - 4 score ≥ 6.
Up to 1 week after ICU discharge
Symptoms of PTSD in family members of ICU survivors
Time Frame: Up to 1 week after ICU discharge
PTSD-related symptoms measured using the IES - 6, summed score range from 0 (best) to 24 (worst)): Presence of PTSD symptoms if averaged IES - 6 score ≥ 1.75.
Up to 1 week after ICU discharge
Physical impairment in family members of ICU survivors
Time Frame: Between the 3rd - 7th day of ICU admission
Symptoms of clinically significant fatigue. Clinical fatigue measured using 4 items of the "energy/fatigue" subscale (Vt) of SF - 36. Averaged score range from 100 (best) to 0 (worst): Presence of clinical fatigue if averaged SF - 36 Vt score < 45.
Between the 3rd - 7th day of ICU admission
Physical impairment in family members of ICU survivors
Time Frame: Up to 1 week after ICU discharge
Symptoms of clinically significant fatigue. Clinical fatigue measured using 4 items of the "energy/fatigue" subscale (Vt) of SF - 36. Averaged score range from 100 (best) to 0 (worst): Presence of clinical fatigue if averaged SF - 36 Vt score < 45.
Up to 1 week after ICU discharge
Cognitive impairment in family members of ICU survivors
Time Frame: Between the 3rd - 7th day of ICU admission
Cognitive impairment measured using the MEFO test. Summed score range from 13 (best) to 0 (worst). Presence of cognitive impairment if summed MEFO test score < 9.
Between the 3rd - 7th day of ICU admission
Cognitive impairment in family members of ICU survivors
Time Frame: Up to 1 week after ICU discharge
Cognitive impairment measured using the MEFO test. Summed score range from 13 (best) to 0 (worst). Presence of cognitive impairment if summed MEFO test score < 9.
Up to 1 week after ICU discharge
Perceived Social Support in family members of ICU survivors
Time Frame: Between the 3rd - 7th day of ICU admission
Perceived social support measured using the modified 8-item version of the Medical Outcomes Study Social Support Survey (mMOS - SSS). Averaged score range from 100 (best) to 0 (worst).
Between the 3rd - 7th day of ICU admission
Perceived Social Support in family members of ICU survivors
Time Frame: Up to 1 week after ICU discharge
Perceived social support measured using the modified 8-item version of the Medical Outcomes Study Social Support Survey (mMOS - SSS). Averaged score range from 100 (best) to 0 (worst).
Up to 1 week after ICU discharge
Perceived Social Support in family members of ICU survivors
Time Frame: 3 months after hospital discharge
Perceived social support measured using the modified 8-item version of the Medical Outcomes Study Social Support Survey (mMOS - SSS). Averaged score range from 100 (best) to 0 (worst).
3 months after hospital discharge
Perceived Social Support in family members of ICU survivors
Time Frame: 6 months after hospital discharge
Perceived social support measured using the modified 8-item version of the Medical Outcomes Study Social Support Survey (mMOS - SSS). Averaged score range from 100 (best) to 0 (worst).
6 months after hospital discharge
Resilience in family members of ICU survivors
Time Frame: Between the 3rd - 7th day of ICU admission
Resilience measured using the Brief Resilient Coping Scale (BRCS). Summed score range from 20 (best) to 4 (worst). Presence of low resilience if summed BRCS score ≤ 13.
Between the 3rd - 7th day of ICU admission
Resilience in family members of ICU survivors
Time Frame: Up to 1 week after ICU discharge
Resilience measured using the Brief Resilient Coping Scale (BRCS). Summed score range from 20 (best) to 4 (worst). Presence of low resilience if summed BRCS score ≤ 13.
Up to 1 week after ICU discharge
Resilience in family members of ICU survivors
Time Frame: 3 months after hospital discharge
Resilience measured using the Brief Resilient Coping Scale (BRCS). Summed score range from 20 (best) to 4 (worst). Presence of low resilience if summed BRCS score ≤ 13.
3 months after hospital discharge
Resilience in family members of ICU survivors
Time Frame: 6 months after hospital discharge
Resilience measured using the Brief Resilient Coping Scale (BRCS). Summed score range from 20 (best) to 4 (worst). Presence of low resilience if summed BRCS score ≤ 13.
6 months after hospital discharge
Family Satisfaction in family members of ICU survivors
Time Frame: Between the 3rd - 7th day of ICU admission
Family satisfaction measured using the Family Satisfaction with Care in the Intensive Care Unit - 24 (FS ICU - 24). Averaged score range from 100 (best) to 0 (worst).
Between the 3rd - 7th day of ICU admission
Family Satisfaction in family members of ICU survivors
Time Frame: Up to 1 week after ICU discharge
Family satisfaction measured using the Family Satisfaction with Care in the Intensive Care Unit - 24 (FS ICU - 24). Averaged score range from 100 (best) to 0 (worst).
Up to 1 week after ICU discharge
Caregiver Burden in family members of ICU survivors
Time Frame: 3 months after hospital discharge
Caregiver Burden measured using the 7-item version of the ZARIT Burden Interview (ZBI). Summed score range from 7 (best) to 35 (worst). Presence of intense caregiver burden if summed ZBI score ≥ 17.
3 months after hospital discharge
Caregiver Burden in family members of ICU survivors
Time Frame: 6 months after hospital discharge
Caregiver Burden measured using the 7-item version of the ZARIT Burden Interview (ZBI). Summed score range from 7 (best) to 35 (worst). Presence of intense caregiver burden if summed ZBI score ≥ 17.
6 months after hospital discharge
Functional Independence in ICU survivors
Time Frame: Between the 3rd - 7th day of ICU admission (prior ICU admission status)
Patient´s functional independence using the Barthel Index (BI). Summed score range from 100 (best) to 0 (worst)
Between the 3rd - 7th day of ICU admission (prior ICU admission status)
Functional Independence in ICU survivors
Time Frame: Up to 1 week after ICU discharge
Patient´s functional independence using the Barthel Index (BI). Summed score range from 100 (best) to 0 (worst)
Up to 1 week after ICU discharge
Functional Independence in ICU survivors
Time Frame: 3 months after hospital discharge
Patient´s functional independence using the Barthel Index (BI). Summed score range from 100 (best) to 0 (worst)
3 months after hospital discharge
Functional Independence in ICU survivors
Time Frame: 6 months after hospital discharge
Patient´s functional independence using the Barthel Index (BI). Summed score range from 100 (best) to 0 (worst)
6 months after hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cristobal Padilla F., PhD, Pontificia Universidad Catolica de Chile

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 27, 2023

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

March 29, 2023

First Submitted That Met QC Criteria

April 11, 2023

First Posted (Actual)

April 25, 2023

Study Record Updates

Last Update Posted (Actual)

April 9, 2024

Last Update Submitted That Met QC Criteria

April 5, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Fondecyt Iniciacion 11230203
  • 11230203 (Other Grant/Funding Number: ANID / FONDECYT)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

3
Subscribe